NHS Launches World's First National Cancer Gene Register

A New Era of Cancer Prevention

NHS England announced on Thursday the creation of the world's first comprehensive genetic register designed to identify people at higher risk of developing cancer. The National Inherited Cancer Predisposition Register will track 120 genes known to increase cancer likelihood, enabling tens of thousands of patients and their family members to determine whether they carry inherited genetic mutations that elevate their risk.

How It Works

Those identified as carrying cancer-linked mutations will be automatically enrolled in screening programmes and offered routine tests. The database will enable clinicians to match patients with treatments most likely to be effective based on their genetic profiles, potentially reducing trial-and-error approaches to therapy. Cancer patients and their family members can have their genes compared to the database, allowing for earlier screening and more personalised treatments.

Building on Success

The initiative expands upon the NHS's Lynch syndrome register, which has now helped more than 12,000 people receive additional bowel screening after being identified as at higher risk. More than 275 Lynch syndrome champions have been trained, covering over 95 percent of cancer teams across England. The Lynch syndrome programme has demonstrated that screening prevents between 40 and 60 out of every 100 people with the condition from developing bowel cancer.

Why It Matters

Health Secretary Wes Streeting framed the database as central to modernising the NHS for the twenty-first century, noting that while half of all people will develop cancer during their lifetime, genetic predisposition plays a substantial role in determining individual risk. Professor Peter Johnson, NHS England's National Clinical Director for Cancer, said finding out about inherited cancer risk can be life-changing, supporting people to access tailored advice on risk-reducing steps and vital monitoring.

Impact on Patients

Claire Rowney, chief executive of Breast Cancer Now, welcomed the announcement as having the potential to transform lives, particularly for women at elevated risk of breast cancer due to family history or genetics. According to research, 5 to 10 percent of women with breast cancer are thought to have an inherited altered gene that increases their risk. The register is part of the NHS Genomics Population Health Service as outlined in the NHS 10 Year Health Plan.